Log in to save to my catalogue

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5770597

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

About this item

Full title

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2018-01, Vol.32 (1), p.139-148

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The molecular basis of advanced systemic mastocytosis (SM) is not fully understood and despite novel therapies the prognosis remains dismal. Exome sequencing of an index-patient with mast cell leukemia (MCL) uncovered biallelic loss-of-function mutations in the
SETD2
histone methyltransferase gene. Copy-neutral loss-of-heterozygosity at 3p21....

Alternative Titles

Full title

SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5770597

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5770597

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/leu.2017.183

How to access this item